Adipose-derived Stem Cells (ADSCs) for Knee Osteoarthritis
A Phase I/II Study to Evaluate the Safety and Efficacy of the Allogeneic Injection of Expanded Adipose-derived Stem Cells to Patients With Knee Osteoarthritis
Sponsor: A2 Healthcare Taiwan Corporation
A PHASE1/PHASE2 clinical study on Knee Osteoarthritis, this trial is completed. The trial is conducted by A2 Healthcare Taiwan Corporation and has accumulated 12 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
▶ Show 7 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Oct 2019 — Dec 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
May 2019 — Oct 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2018 — May 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Dec 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- A2 Healthcare Taiwan Corporation
- UnicoCell Biomed CO. LTD
For direct contact, visit the study record on ClinicalTrials.gov .